Reumatología y Enfermedades Inmuno-mediadas ‘IRIDIS’

Artículos Científicos

• Álvaro Gracia JM, Sanchez-Piedra C, Manero J, Ruiz-Lucea ME, López-Vives L, Bohorquez C, Martinez-Barrio J, Bonilla G, Vela P, García-Villanueva MJ, Navío-Marco MT, Pavía M, Galindo M, Erausquin C, Gonzalez-Gay MA, Rua-Figueroa I, Pego-Reigosa JM, Castrejon I, Sanchez-Costa JT, González-Dávila E, Diaz-Gonzalez F; COVIDSER study group. Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study. RMD Open. 2021 Dec;7(3). pii: e001925. doi: 10.1136/rmdopen-2021-001925. PubMed PMID: 34887346; PubMed Central PMCID: PMC8662584. +Pubmed +DOI
• Álvaro Gracia JM, Sanchez-Piedra C, Manero J, Ruiz-Lucea ME, López-Vives L, Bohorquez C, Martinez-Barrio J, Bonilla G, Vela P, García-Villanueva MJ, Navío-Marco MT, Pavía M, Galindo M, Erausquin C, Gonzalez-Gay MA, Rua-Figueroa I, Pego-Reigosa JM, Castrejon I, Sanchez-Costa JT, González-Dávila E, Diaz-Gonzalez F, COVIDSER study group. Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study. RMD open. 2021;7(3):e001925. PMID: 34887346. DOI: 10.1136/rmdopen-2021-001925. http://www.ncbi.nlm.nih.gov/pubmed/34887346 +Pubmed +DOI
• Aringer M, Brinks R, Dörner T, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Schmajuk G, Tani C, Tedeschi SK, Touma Z, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Costenbader K, Johnson SR. European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance. Ann Rheum Dis. 2021 Feb;(E-PUB) PMID: 33568386. DOI: 10.1136/annrheumdis-2020-219373. http://www.ncbi.nlm.nih.gov/pubmed/33568386 +Pubmed +DOI
• Aringer M, Brinks R, Dörner T, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Schmajuk G, Tani C, Tedeschi SK, Touma Z, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Costenbader K, Johnson SR. European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance. Ann Rheum Dis. 2021 Feb;(E-PUB) PMID: 33568386. DOI: 10.1136/annrheumdis-2020-219373. http://www.ncbi.nlm.nih.gov/pubmed/33568386 +Pubmed +DOI
• Blanco FJ, Silva-Díaz M, Quevedo Vila V, Seoane-Mato D, Pérez Ruiz F, Juan-Mas A, Pego-Reigosa JM, Narváez J, Quilis N, Cortés R, Romero Pérez A, Fábregas Canales D, Font Gayá T, Bordoy Ferrer C, Sánchez-Piedra C, Díaz-González F, Bustabad-Reyes S; EPISER2016 Project Working Group. Prevalence of symptomatic osteoarthritis in Spain: EPISER2016 study. Reumatol Clin (Engl Ed). 2021 Oct;17(8):461-470. doi: 10.1016/j.reumae.2020.01.005. Epub 2020 Nov 24. PubMed PMID: 34625149. +Pubmed +DOI
• Blanco FJ, Silva-Díaz M, Quevedo Vila V, Seoane-Mato D, Pérez Ruiz F, Juan-Mas A, Pego-Reigosa JM, Narváez J, Quilis N, Cortés R, Romero Pérez A, Fábregas Canales D, Font Gayá T, Bordoy Ferrer C, Sánchez-Piedra C, Díaz-González F, Bustabad-Reyes S, EPISER2016 Project Working Group. Prevalence of symptomatic osteoarthritis in Spain: EPISER2016 study. Reumatol Clin. 2021 Oct;17(8):461–70. PMID: 34625149. DOI: 10.1016/j.reumae.2020.01.005. http://www.ncbi.nlm.nih.gov/pubmed/32360025 +Pubmed +DOI
• Blanco Pérez JJ, Arnalich Montiel V, Salgado-Barreira Á, Alvarez Moure MA, Caldera Díaz AC, Melero Gonzalez R, Pallarés Sanmartín A, Fernandez Villar A, González Barcala FJ. Prevalence and Clinical Impact of Systemic Autoimmune Rheumatic Disease in Patients with Silicosis. Arch Bronconeumol. 2021 May;57(9):571–6. PMID: 32493645. DOI: 10.1016/j.arbres.2020.04.012. http://www.ncbi.nlm.nih.gov/pubmed/32493645 +Pubmed +DOI
• Cobo-Ibáñez T, Sánchez-Piedra C, Nuño-Nuño L, Castellví I, Carrión-Barberà I, Romero-Bueno F, Narváez J, Trallero-Araguás E, Tomero E, Ruiz-Lucea ME, Larena C, Carrasco Cubero C, Jovaní V, Barbadillo C, Sivera F, Belzunegui J, Pérez Gómez A, Gómez Gómez A, Delgado-Frías E, Pego-Reigosa JM, Joven B, Ibáñez M, Martínez-González O, Ruiz-Román A, Camins J, Ortega-Castro R, Trenor Larra P, Rodríguez López M, Freire M, Alcocer P, Holgado S, Rúa-Figueroa I, Lozano N, Martínez-Barrio J. Myo-Spain: Spanish Registry of Patients with Idiopathic Inflammatory Myopathy. Methodology. Reumatol Clin (Engl Ed). 2021 Apr 15. pii: S1699-258X(21)00065-6. doi: 10.1016/j.reuma.2021.01.007. [Epub ahead of print] English, Spanish. PubMed PMID: 33867271. +Pubmed +DOI
• Cobo-Ibáñez T, Sánchez-Piedra C, Nuño-Nuño L, Castellví I, Carrión-Barberà I, Romero-Bueno F, Narváez J, Trallero-Araguás E, Tomero E, Ruiz-Lucea ME, Larena C, Carrasco Cubero C, Jovaní V, Barbadillo C, Sivera F, Belzunegui J, Pérez Gómez A, Gómez Gómez A, Delgado-Frías E, Pego-Reigosa JM, Joven B, Ibáñez M, Martínez-González O, Ruiz-Román A, Camins J, Ortega-Castro R, Trenor Larra P, Rodríguez López M, Freire M, Alcocer P, Holgado S, Rúa-Figueroa I, Lozano N, Martínez-Barrio J. Myo-Spain: Spanish Registry of patients with idiopathic inflammatory myopathy. Methodology. Reumatol Clin (Engl Ed). 2021 Aug 13. pii: S2173-5743(21)00156-8. doi: 10.1016/j.reumae.2021.01.004. [Epub ahead of print] PubMed PMID: 34400117. +Pubmed +DOI
• Cobo-Ibáñez T, Sánchez-Piedra C, Nuño-Nuño L, Castellví I, Carrión-Barberà I, Romero-Bueno F, Narváez J, Trallero-Araguás E, Tomero E, Ruiz-Lucea ME, Larena C, Carrasco Cubero C, Jovaní V, Barbadillo C, Sivera F, Belzunegui J, Pérez Gómez A, Gómez Gómez A, Delgado-Frías E, Pego-Reigosa JM, Joven B, Ibáñez M, Martínez-González O, Ruiz-Román A, Camins J, Ortega-Castro R, Trenor Larra P, Rodríguez López M, Freire M, Alcocer P, Holgado S, Rúa-Figueroa I, Lozano N, Martínez-Barrio J. Myo-Spain: Spanish Registry of patients with idiopathic inflammatory myopathy. Methodology. Reumatol Clin. 2021 Aug;(E-PUB):S2173-5743(21)00156-8. PMID: 34400117. DOI: 10.1016/j.reumae.2021.01.004. http://www.ncbi.nlm.nih.gov/pubmed/34400117 +Pubmed +DOI
• Cordero OJ, Rafael-Vidal C, Varela-Calviño R, Calviño-Sampedro C, Malvar-Fernández B, García S, Viñuela JE, Pego-Reigosa JM. Distinctive CD26 Expression on CD4 T-Cell Subsets. Biomolecules. 2021 Oct 2;11(10). pii: 1446. doi: 10.3390/biom11101446. PubMed PMID: 34680079; PubMed Central PMCID: PMC8533622. +Pubmed +DOI
• Cordero OJ, Rafael-Vidal C, Varela-Calviño R, Calviño-Sampedro C, Malvar-Fernández B, García S, Viñuela JE, Pego-Reigosa JM. Distinctive CD26 Expression on CD4 T-Cell Subsets. Biomolecules. 2021;11(10):1446. PMID: 34680079. DOI: 10.3390/biom11101446. http://www.ncbi.nlm.nih.gov/pubmed/34680079 +Pubmed +DOI
• García-Beloso N, Altabás-González I, Samartín-Ucha M, Gayoso-Rey M, De Castro-Parga ML, Salgado-Barreira Á, Cibeira-Badia A, Piñeiro-Corrales MG, González-Vilas D, Pego-Reigosa JM, Martínez-López de Castro N. Switching between reference adalimumab and biosimilars in chronic immune-mediated inflammatory diseases: A systematic literature review. Br J Clin Pharmacol. 2021 Oct 8. doi: 10.1111/bcp.15101. [Epub ahead of print] Review. PubMed PMID: 34622969. +Pubmed +DOI
• García-Beloso N, Altabás-González I, Samartín-Ucha M, Gayoso-Rey M, De Castro-Parga ML, Salgado-Barreira Á, Cibeira-Badia A, Piñeiro-Corrales MG, González-Vilas D, Pego-Reigosa JM, Martínez-López de Castro N. Switching between reference adalimumab and biosimilars in chronic immune-mediated inflammatory diseases: A systematic literature review. Br J Clin Pharmacol. 2021 Oct; PMID: 34622969. DOI: 10.1111/bcp.15101. http://www.ncbi.nlm.nih.gov/pubmed/34622969 +Pubmed +DOI
• Martínez-López-de-Castro N, Álvarez-Payero M, Samartín-Ucha M, Martínez-Reglero C, Martín-Vila A, Rodríguez-Rodríguez M, Piñeiro-Corrales G, Maceiras-Pan JF, Melero-González RB, Pego-Reigosa JM. Direct costs in patients with chronic inflammatory arthropathies on biological therapy: a real-world data study. Clin Exp Rheumatol. 2021 Sep;39(4):736–45. PMID: 32896255. https://pubmed.ncbi.nlm.nih.gov/32896255/ +Pubmed
• Martínez-López-de-Castro N, Álvarez-Payero M, Samartín-Ucha M, Martínez-Reglero C, Martín-Vila A, Rodríguez-Rodríguez M, Piñeiro-Corrales G, Maceiras-Pan JF, Melero-González RB, Pego-Reigosa JM. Direct costs in patients with chronic inflammatory arthropathies on biological therapy: a real-world data study. Clin Exp Rheumatol. 2021 Sep;39(4):736–45. PMID: 32896255. https://pubmed.ncbi.nlm.nih.gov/32896255/ +Pubmed
• Martínez-López-de-Castro N, Samartín-Ucha M, Paradela-Carreiro A, Pérez-Landeiro A, Inaraja-Bobo MT, Álvarez-Payero M, Castro-Núñez I, García-Beloso N, Robles-Torres D, López-López A, González-Costas S, Leboreiro-Enríquez B, Otero-Millán L, Yaiza Romero-Ventosa E, Casanova-Martínez C, Lorenzo-Lorenzo K, Regueira-Arcay AM, Vázquez-López C, Martínez-Reglero C, Piñeiro-Corrales G. Real-world prevalence and consequences of potential drug-drug interactions in the first-wave COVID-19 treatments. J Clin Pharm Ther. 2021 Jun;46(3):724–30. PMID: 33368439. DOI: 10.1111/jcpt.13337. http://www.ncbi.nlm.nih.gov/pubmed/33368439 +Pubmed +DOI
• Martínez-López-de-Castro N, Samartín-Ucha M, Paradela-Carreiro A, Pérez-Landeiro A, Inaraja-Bobo MT, Álvarez-Payero M, Castro-Núñez I, García-Beloso N, Robles-Torres D, López-López A, González-Costas S, Leboreiro-Enríquez B, Otero-Millán L, Yaiza Romero-Ventosa E, Casanova-Martínez C, Lorenzo-Lorenzo K, Regueira-Arcay AM, Vázquez-López C, Martínez-Reglero C, Piñeiro-Corrales G. Real-world prevalence and consequences of potential drug-drug interactions in the first-wave COVID-19 treatments. J Clin Pharm Ther. 2021 Jun;46(3):724–30. PMID: 33368439. DOI: 10.1111/jcpt.13337. http://www.ncbi.nlm.nih.gov/pubmed/33368439 +Pubmed +DOI
• Mucke J, Alarcon-Riquelme M, Andersen J, Aringer M, Bombardieri S, Brinks R, Cervera R, Chehab G, Cornet A, Costedoat-Chalumeau N, Czirják L, Doria A, Fischer-Betz R, Furie RA, Gatto M, Houssiau FA, Ines L, Liang MH, Morand E, Mosca M, Pego-Reigosa JM, Rúa-Figueroa I, Ruiz-Irastorza G, Terrier B, Voss A, Schneider M. What are the topics you care about making trials in lupus more effective? Results of an Open Space meeting of international lupus experts. Lupus Sci Med. 2021 May;8(1). pii: e000506. doi: 10.1136/lupus-2021-000506. PubMed PMID: 34016719; PubMed Central PMCID: PMC8141446. +Pubmed +DOI
• Mucke J, Alarcon-Riquelme M, Andersen J, Aringer M, Bombardieri S, Brinks R, Cervera R, Chehab G, Cornet A, Costedoat-Chalumeau N, Czirják L, Doria A, Fischer-Betz R, Furie RA, Gatto M, Houssiau FA, Ines L, Liang MH, Morand E, Mosca M, Pego-Reigosa JM, Rúa-Figueroa I, Ruiz-Irastorza G, Terrier B, Voss A, Schneider M. What are the topics you care about making trials in lupus more effective? Results of an Open Space meeting of international lupus experts. Lupus Sci Med. 2021;8(1):e000506. PMID: 34016719. DOI: 10.1136/lupus-2021-000506. http://www.ncbi.nlm.nih.gov/pubmed/34016719 +Pubmed +DOI
• Pego-Reigosa JM, Nicholson L, Pooley N, Langham S, Embleton N, Marjenberg Z, Barut V, Desta B, Wang X, Langham J, Hammond ER. The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis. Rheumatology (Oxford). 2021 Oct;60(1):60–72. PMID: 33099651. DOI: 10.1093/rheumatology/keaa478. http://www.ncbi.nlm.nih.gov/pubmed/33099651 +Pubmed +DOI
• Pego-Reigosa JM, Nicholson L, Pooley N, Langham S, Embleton N, Marjenberg Z, Barut V, Desta B, Wang X, Langham J, Hammond ER. The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis. Rheumatology (Oxford). 2021 Oct;60(1):60–72. PMID: 33099651. DOI: 10.1093/rheumatology/keaa478. http://www.ncbi.nlm.nih.gov/pubmed/33099651 +Pubmed +DOI
• Pego-Reigosa JM, Restrepo Vélez J, Baldini C, Rúa-Figueroa Fernández de Larrinoa Í. Comorbidities (excluding lymphoma) in Sjögren´s syndrome. Rheumatology (Oxford). 2021 Feb;60(5):2075–84. PMID: 30770715. DOI: 10.1093/rheumatology/key329. http://www.ncbi.nlm.nih.gov/pubmed/30770715 +Pubmed +DOI
• Pego-Reigosa JM, Restrepo Vélez J, Baldini C, Rúa-Figueroa Fernández de Larrinoa Í. Comorbidities (excluding lymphoma) in Sjögren´s syndrome. Rheumatology (Oxford). 2021 Feb;60(5):2075–84. PMID: 30770715. DOI: 10.1093/rheumatology/key329. http://www.ncbi.nlm.nih.gov/pubmed/30770715 +Pubmed +DOI
• Prieto-Peña D, Bernabeu P, Vela P, Narváez J, Fernández-López JC, Freire-González M, González-Álvarez B, Solans-Laqué R, Callejas Rubio JL, Ortego N, Fernández-Díaz C, Rubio E, García-Morillo S, Minguez M, Fernández-Carballido C, de Miguel E, Melchor S, Salgado E, Bravo B, Romero-Yuste S, Salvatierra J, Hidalgo C, Manrique S, Romero-Gómez C, Moya P, Álvarez-Rivas N, Mendizabal J, Ortiz-Sanjuán F, Pérez de Pedro I, Alonso-Valdivielso JL, Perez-Sanchez L, Roldán R, Fernandez-Llanio N, Gómez de la Torre R, Suarez S, Montesa Cabrera MJ, Delgado Sánchez M, Loricera J, Atienza-Mateo B, Castañeda S, González-Gay MA, Blanco R. Tocilizumab in refractory Caucasian Takayasu´s arteritis: a multicenter study of 54 patients and literature review. Ther Adv Musculoskelet Dis. 2021;13:1759720X211020917. PMID: 34211589. DOI: 10.1177/1759720X211020917. http://www.ncbi.nlm.nih.gov/pubmed/34211589 +Pubmed +DOI
• Prieto-Peña D, Bernabeu P, Vela P, Narváez J, Fernández-López JC, Freire-González M, González-Álvarez B, Solans-Laqué R, Callejas Rubio JL, Ortego N, Fernández-Díaz C, Rubio E, García-Morillo S, Minguez M, Fernández-Carballido C, de Miguel E, Melchor S, Salgado E, Bravo B, Romero-Yuste S, Salvatierra J, Hidalgo C, Manrique S, Romero-Gómez C, Moya P, Álvarez-Rivas N, Mendizabal J, Ortiz-Sanjuán F, Pérez de Pedro I, Alonso-Valdivielso JL, Perez-Sanchez L, Roldán R, Fernandez-Llanio N, Gómez de la Torre R, Suarez S, Montesa Cabrera MJ, Delgado Sánchez M, Loricera J, Atienza-Mateo B, Castañeda S, González-Gay MA, Blanco R. Tocilizumab in refractory Caucasian Takayasu´s arteritis: a multicenter study of 54 patients and literature review. Ther Adv Musculoskelet Dis. 2021;13:1759720X211020917. PMID: 34211589. DOI: 10.1177/1759720X211020917. http://www.ncbi.nlm.nih.gov/pubmed/34211589 +Pubmed +DOI
• Rafael-Vidal C, Altabás I, Pérez N, Mourino Rodríguez C, Pego-Reigosa JM, Garcia S. Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis. Int J Mol Sci. 2021 Jan;22(3) PMID: 33514066. DOI: 10.3390/ijms22031263. http://www.ncbi.nlm.nih.gov/pubmed/33514066 +Pubmed +DOI
• Rafael-Vidal C, Altabás I, Pérez N, Mourino Rodríguez C, Pego-Reigosa JM, Garcia S. Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis. Int J Mol Sci. 2021 Jan;22(3) PMID: 33514066. DOI: 10.3390/ijms22031263. http://www.ncbi.nlm.nih.gov/pubmed/33514066 +Pubmed +DOI
• Riancho-Zarrabeitia L, Martínez-Taboada VM, Rúa-Figueroa I, Alonso F, Galindo-Izquierdo M, Ovalles J, Olivé-Marqués A, Mena Vázquez N, Calvo-Alén J, Menor Almagro R, Tomero Muriel E, Uriarte Isacelaya E, Boteanu A, Andres M, Freire González M, Santos Soler G, Ruiz-Lucea ME, Ibáñez-Barceló M, Castellví I, Galisteo C, Quevedo Vila V, Raya E, Narváez J, Expósito L, Hernández Beriaín JA, Horcada L, Aurrecoechea E, Pego Reigosa JM. Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients? Clin Exp Rheumatol. 2021;39(3):555–63. PMID: 32828148. http://www.ncbi.nlm.nih.gov/pubmed/32828148 +Pubmed
• Riveros Frutos A, Holgado S, Sanvisens Bergé A, Casas I, Olivé A, López-Longo FJ, Calvo-Alén J, Galindo M, Fernández-Nebro A, Pego-Reigosa JM, Rúa-Figueroa I, RELESSER Group. Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER). Rheumatology (Oxford). 2021 Oct;60(4):1793–803. PMID: 33106841. DOI: 10.1093/rheumatology/keaa477. http://www.ncbi.nlm.nih.gov/pubmed/33106841 +Pubmed +DOI
• Riveros Frutos A, Holgado S, Sanvisens Bergé A, Casas I, Olivé A, López-Longo FJ, Calvo-Alén J, Galindo M, Fernández-Nebro A, Pego-Reigosa JM, Rúa-Figueroa I, RELESSER Group. Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER). Rheumatology (Oxford). 2021 Oct;60(4):1793–803. PMID: 33106841. DOI: 10.1093/rheumatology/keaa477. http://www.ncbi.nlm.nih.gov/pubmed/33106841 +Pubmed +DOI
• Rúa-Figueroa Fernández de Larrinoa Í, Carreira PE, Brito García N, Díaz Del Campo Fontecha P, Pego Reigosa JM, Gómez Puerta JA, Ortega-Castro R, Tejera Segura B, Aguado García JM, Torre-Cisneros J, Valencia-Martín JL, Pereda CA, Nishishinya-Aquino MB, Otón Sánchez MT, Silva Fernández L, Maese Manzano J, Chamizo Carmona E, Correyero Plaza M. Recommendations for prevention of infection in systemic autoimmune rheumatic diseases. Reumatol Clin (Engl Ed). 2021 Jun 24. pii: S1699-258X(21)00124-8. doi: 10.1016/j.reuma.2021.04.006. [Epub ahead of print] English, Spanish. PubMed PMID: 34176767. +Pubmed +DOI
• Rúa-Figueroa Fernández de Larrinoa Í, Carreira PE, Brito García N, Díaz Del Campo Fontecha P, Pego Reigosa JM, Gómez Puerta JA, Ortega-Castro R, Tejera Segura B, Aguado García JM, Torre-Cisneros J, Valencia-Martín JL, Pereda CA, Nishishinya-Aquino MB, Otón Sánchez MT, Silva Fernández L, Maese Manzano J, Chamizo Carmona E, Correyero Plaza M. Recommendations for prevention of infection in systemic autoimmune rheumatic diseases. Reumatol Clin (Engl Ed). 2021 Oct 1. pii: S2173-5743(21)00167-2. doi: 10.1016/j.reumae.2021.04.003. [Epub ahead of print] PubMed PMID: 34607782. +Pubmed +DOI
• Rúa-Figueroa Fernández de Larrinoa Í, Carreira PE, Brito García N, Díaz Del Campo Fontecha P, Pego Reigosa JM, Gómez Puerta JA, Ortega-Castro R, Tejera Segura B, Aguado García JM, Torre-Cisneros J, Valencia-Martín JL, Pereda CA, Nishishinya-Aquino MB, Otón Sánchez MT, Silva Fernández L, Maese Manzano J, Chamizo Carmona E, Correyero Plaza M. Recommendations for prevention of infection in systemic autoimmune rheumatic diseases. Reumatol Clin. 2021 Jun;(E-PUB) PMID: 34176767. DOI: 10.1016/j.reuma.2021.04.006. http://www.ncbi.nlm.nih.gov/pubmed/34176767 +Pubmed +DOI
• Rúa-Figueroa Fernández de Larrinoa I, Pego-Reigosa JM, en representación de los investigadores del proyecto RELESSER y del grupo EAS-SER, Investigadores del registro RELESSER en su fase transversal. Contributions of the lupus register of the Spanish Society of Rheumatology (RELESSER) to the knowledge of systemic lupus erythematosus in Spain. Reumatol Clin. 2021 May;17(5):245–9. PMID: 32205082. DOI: 10.1016/j.reuma.2020.01.006. http://www.ncbi.nlm.nih.gov/pubmed/32205082 +Pubmed +DOI
• Rúa-Figueroa Fernández de Larrinoa I, Pego-Reigosa JM; en representación de los investigadores del proyecto RELESSER y del grupo EAS-SER; Investigadores del registro RELESSER en su fase transversal. Contributions of the lupus register of the Spanish Society of Rheumatology (RELESSER) to the knowledge of systemic lupus erythematosus in Spain. Reumatol Clin (Engl Ed). 2021 May;17(5):245-249. doi: 10.1016/j.reuma.2020.01.006. Epub 2020 Mar 21. English, Spanish. PubMed PMID: 32205082. +Pubmed +DOI
• Samartín-Ucha M, Pego-Reigosa JM, Álvarez-Payero M, Martin-Vila A, Pineiro-Corrales G, Rodriguez-Rodriguez M, Melero-Gonzalez RB, Maceiras-Pan F, Martinez-Reglero C, Mrtinez-Lopez de Castro N. Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study. Eur J Hosp Pharm. 2021 Nov;28(Suppl2):e47-e50 PMID: 32404382. DOI: 10.1136/ejhpharm-2019-002133. http://www.ncbi.nlm.nih.gov/pubmed/32404382 +Pubmed +DOI
• Samartín-Ucha M, Pego-Reigosa JM, Álvarez-Payero M, Martin-Vila A, Pineiro-Corrales G, Rodriguez-Rodriguez M, Melero-Gonzalez RB, Maceiras-Pan F, Martinez-Reglero C, Mrtinez-Lopez de Castro N. Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study. Eur J Hosp Pharm Sci Pract. 2021 Nov;28(Suppl 2):e47–50. PMID: 32404382. DOI: 10.1136/ejhpharm-2019-002133. http://www.ncbi.nlm.nih.gov/pubmed/32404382 +Pubmed +DOI
• Silva-Díaz M, Blanco FJ, Quevedo Vila V, Seoane-Mato D, Pérez-Ruiz F, Juan-Mas A, Pego-Reigosa JM, Narváez J, Quilis N, Cortés R, Romero Pérez A, Fábregas Canales D, Font Gayá T, Bordoy Ferrer C, Prado-Galbarro FJ, Sánchez-Piedra C, Díaz-González F, Bustabad-Reyes S; Working Group Proyecto EPISER2016. Prevalence of symptomatic axial osteoarthritis phenotypes in Spain and associated socio-demographic, anthropometric, and lifestyle variables. Rheumatol Int. 2021 Nov 10. doi: 10.1007/s00296-021-05038-4. [Epub ahead of print] PubMed PMID: 34755205. +Pubmed +DOI
• Silva-Díaz M, Blanco FJ, Quevedo Vila V, Seoane-Mato D, Pérez-Ruiz F, Juan-Mas A, Pego-Reigosa JM, Narváez J, Quilis N, Cortés R, Romero Pérez A, Fábregas Canales D, Font Gayá T, Bordoy Ferrer C, Prado-Galbarro FJ, Sánchez-Piedra C, Díaz-González F, Bustabad-Reyes S, Working Group Proyecto EPISER2016. Prevalence of symptomatic axial osteoarthritis phenotypes in Spain and associated socio-demographic, anthropometric, and lifestyle variables. Rheumatol Int. 2021 Nov;(E-PUB) PMID: 34755205. DOI: 10.1007/s00296-021-05038-4. http://www.ncbi.nlm.nih.gov/pubmed/34755205 +Pubmed +DOI
• Tejera Segura B, Altabás González I, Rúa-Figueroa I, Pérez Veiga N, Del Campo Pérez V, Olivé-Marqués A, Galindo M, Calvo J, Ovalles-Bonilla JG, Fernández-Nebro A, Menor-Almagro R, Tomero E, Del Val Del Amo N, Uriarte Isacelaya E, Martínez-Taboada VM, Andreu JL, Boteanu A, Narváez J, Movasat A, Montilla C, Senabre Gallego JM, Hernández-Cruz B, Andrés M, Salgado E, Freire M, Machín García S, Moriano C, Expósito L, Pérez Velásquez C, Velloso-Feijoo ML, Cacheda AP, Lozano-Rivas N, Bonilla G, Arévalo M, Jiménez I, Quevedo-Vila V, Manero-Ruiz FJ, García de la Peña Lefebvre P, Vázquez-Rodríguez TR, Ibañez-Rua J, Cobo-Ibañez T, Pego-Reigosa JM. Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know? Rheumatology (Oxford). 2021 Nov 3;60(11):5329-5336. doi: 10.1093/rheumatology/keab401. PubMed PMID: 33950249. +Pubmed +DOI
• Tejera Segura B, Altabás González I, Rúa-Figueroa I, Pérez Veiga N, Del Campo Pérez V, Olivé-Marqués A, Galindo M, Calvo J, Ovalles-Bonilla JG, Fernández-Nebro A, Menor-Almagro R, Tomero E, Del Val Del Amo N, Uriarte Isacelaya E, Martínez-Taboada VM, Andreu JL, Boteanu A, Narváez J, Movasat A, Montilla C, Senabre Gallego JM, Hernández-Cruz B, Andrés M, Salgado E, Freire M, Machín García S, Moriano C, Expósito L, Pérez Velásquez C, Velloso-Feijoo ML, Cacheda AP, Lozano-Rivas N, Bonilla G, Arévalo M, Jiménez I, Quevedo-Vila V, Manero-Ruiz FJ, García de la Peña Lefebvre P, Vázquez-Rodríguez TR, Ibañez-Rua J, Cobo-Ibañez T, Pego-Reigosa JM. Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know? Rheumatology (Oxford). 2021;60(11):5329–36. PMID: 33950249. DOI: 10.1093/rheumatology/keab401. http://www.ncbi.nlm.nih.gov/pubmed/33950249 +Pubmed +DOI
• Verdú RC, Pego-Reigosa JM, Seoane-Mato D, Valle MM, Sánchez DP, Martínez MJM, González MM, Buruaga JAS de, Onaindia IU, Cáceres BAB, Silva-Fernández L, Sivera F, Blanco FJ, Sánchez-Piedra C, Díaz-González F, Bustabad S, Working Group Proyecto EPISER2016. Comment on: Prevalence of systemic lupus erythematosus in Spain: higher than previously reported in other countries? Reply. Rheumatology (Oxford). 2021 Mar;60(3):e120–1. PMID: 33677597. DOI: 10.1093/rheumatology/keaa762. http://www.ncbi.nlm.nih.gov/pubmed/33677597 +Pubmed +DOI
• Wienke J, Mertens JS, Garcia S, Lim J, Wijngaarde CA, Yeo JG, Meyer A, van den Hoogen LL, Tekstra J, Hoogendijk JE, Otten HG, Fritsch-Stork RDE, de Jager W, Seyger MMB, Thurlings RM, de Jong EMGJ, van der Kooi AJ, van der Pol WL, Dutch Juvenile Myositis Consortium, Arkachaisri T, Radstake TRDJ, van Royen-Kerkhof A, van Wijk F. Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular risk. Rheumatology (Oxford). 2021 Aug;60(2):785–801. PMID: 32810267. DOI: 10.1093/rheumatology/keaa270. https://pubmed.ncbi.nlm.nih.gov/32810267/ +Pubmed +DOI

Artículos Científicos

• Blanco FJ, Silva-Díaz M, Quevedo Vila V, Seoane-Mato D, Pérez Ruiz F, Juan-Mas A, Pego-Reigosa JM, Narváez J, Quilis N, Cortés R, Romero Pérez A, Fábregas Canales D, Font Gayá T, Bordoy Ferrer C, Sánchez-Piedra C, Díaz-González F, Bustabad-Reyes S, en representación del Grupo de Trabajo del Proyecto EPISER2016. Prevalence of symptomatic osteoarthritis in Spain: EPISER2016 study. Reumatol Clin. 2020 Apr;(E-PUB) PMID: 32360025. DOI: 10.1016/j.reuma.2020.01.008. http://www.ncbi.nlm.nih.gov/pubmed/32360025 +Pubmed +DOI
• Blanco Pérez JJ, Arnalich Montiel V, Salgado-Barreira Á, Alvarez Moure MA, Caldera Díaz AC, Melero Gonzalez R, Pallarés Sanmartín A, Fernandez Villar A, González Barcala FJ. Prevalence and Clinical Impact of Systemic Autoimmune Rheumatic Disease in Patients with Silicosis. Arch Bronconeumol. 2020 May;(E-PUB) PMID: 32493645. DOI: 10.1016/j.arbres.2020.04.012. http://www.ncbi.nlm.nih.gov/pubmed/32493645 +Pubmed +DOI
• Calderón-Goercke M, Castañeda S, Aldasoro V, Villa I, Prieto-Peña D, Atienza-Mateo B, Patiño E, Moriano C, Romero-Yuste S, Narváez J, Gómez-Arango C, Pérez-Pampín E, Melero R, Becerra-Fernández E, Revenga M, Álvarez-Rivas N, Galisteo C, Sivera F, Olivé-Marqués A, Álvarez Del Buergo M, Marena-Rojas L, Fernández-López C, Navarro F, Raya E, Galindez-Agirregoikoa E, Arca B, Solans-Laqué R, Conesa A, Hidalgo C, Vázquez C, Román-Ivorra JA, Loricera J, Lluch P, Manrique-Arija S, Vela P, De Miguel E, Torres-Martín C, Nieto JC, Ordas-Calvo C, Salgado-Pérez E, Luna-Gomez C, Toyos-Sáenz de Miera FJ, Fernández-Llanio N, García A, Larena C, González-Vela C, Corrales A, Varela-García M, Aurrecoechea E, Dos Santos R, García-Manzanares Á, Ortego N, Fernández S, Ortiz-Sanjuán F, Corteguera M, Hernández JL, González-Gay MÁ, Blanco R. Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice. Clin Exp Rheumatol. 2020;38 Suppl 1(2):112–9. PMID: 3244 +Pubmed
• Calvo-Alén J, Vela P, Bustabad S, Maceiras F, Carmona L, Cea-Calvo L. Satisfaction, fulfillment of expectations and adherence to subcutaneous biological drugs in patients with rheumatoid arthritis: ARCO study. Reumatol Clin. 2020 Mar;16(2 Pt 1):116–9. PMID: 29776887. DOI: 10.1016/j.reuma.2018.02.015. http://www.ncbi.nlm.nih.gov/pubmed/29776887 +Pubmed +DOI
• Carvalheiro T, Garcia S, Pascoal Ramos MI, Giovannone B, Radstake TRDJ, Marut W, Meyaard L. Leukocyte Associated Immunoglobulin Like Receptor 1 Regulation and Function on Monocytes and Dendritic Cells During Inflammation. Front Immunol. 2020;11(August):1793. PMID: 32973751. DOI: 10.3389/fimmu.2020.01793. http://www.ncbi.nlm.nih.gov/pubmed/32973751 +Pubmed +DOI
• Carvalheiro T, Lopes AP, van der Kroef M, Malvar-Fernandez B, Rafael-Vidal C, Hinrichs AC, Servaas NH, Bonte-Mineur F, Kok MR, Beretta L, Zimmermann M, Marut W, Pego-Reigosa JM, Radstake TRDJ, Garcia S. Angiopoietin-2 Promotes Inflammatory Activation in Monocytes of Systemic Sclerosis Patients. Int J Mol Sci. 2020 Dec;21(24):9544. PMID: 33333969. DOI: 10.3390/ijms21249544. https://doi.org/10.3390/ijms21249544 +Pubmed +DOI
• Carvalheiro T, Malvar Fernández B, Ottria A, Giovannone B, Marut W, Reedquist KA, Garcia S, Radstake TR. Extracellular SPARC cooperates with TGF-? signalling to induce pro-fibrotic activation of systemic sclerosis patient dermal fibroblasts. Rheumatol (United Kingdom). 2020;59(9):2258–63. PMID: 31840182. DOI: 10.1093/rheumatology/kez583. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449812/pdf/kez583.pdf +Pubmed +DOI
• Carvalheiro T, Rafael-Vidal C, Malvar-Fernandez B, Lopes AP, Pego-Reigosa JM, Radstake TRDJ, Garcia S. Semaphorin4A-Plexin D1 Axis Induces Th2 and Th17 While Represses Th1 Skewing in an Autocrine Manner. Int J Mol Sci. 2020 Sep;21(18):1–11. PMID: 32971928. DOI: 10.3390/ijms21186965. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555002/pdf/ijms-21-06965.pdf +Pubmed +DOI
• Cobo-Ibáñez T, Urruticoechea-Arana A, Rúa-Figueroa I, Martín-Martínez MA, Ovalles-Bonilla JG, Galindo M, Calvo-Alén J, Olivé A, Fernández-Nebro A, Menor-Almagro R, Tomero E, Horcada L, Uriarte-Itzazelaia E, Martínez-Taboada VM, Andreu JL, Boteanu A, Narváez J, Bohorquez C, Montilla C, Santos G, Hernández-Cruz B, Vela P, Salgado E, Freire M, Hernández-Beriain JÁ, Díez-Álvarez E, Expósito L, Fernández-Berrizbeitia O, Velloso-Feijoo ML, Ibáñez-Barceló M, Lozano-Rivas N, Bonilla G, Moreno M, Raya E, Quevedo-Vila VE, Vázquez-Rodríguez TR, Ibáñez-Ruan J, Muñoz-Fernández S, Sánchez-Alonso F, Pego-Reigosa JM. Hormonal Dependence and Cancer in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2020 Feb;72(2):216–24. PMID: 31529686. DOI: 10.1002/acr.24068. http://www.ncbi.nlm.nih.gov/pubmed/31529686 +Pubmed +DOI
• Cortés Verdú R, Pego-Reigosa JM, Seoane-Mato D, Morcillo Valle M, Palma Sánchez D, Moreno Martínez MJ, Mayor González M, Atxotegi Sáenz de Buruaga J, Urionagüena Onaindia I, Blanco Cáceres BA, Silva-Fernández L, Sivera F, Blanco FJ, Sánchez-Piedra C, Díaz-González F, Bustabad S, Working Group Proyecto EPISER2016. Prevalence of systemic lupus erythematosus in Spain: higher than previously reported in other countries? Rheumatology (Oxford). 2020 Sep;59(9):2556–62. PMID: 31998955. DOI: 10.1093/rheumatology/kez668. https://pubmed.ncbi.nlm.nih.gov/31998955/ +Pubmed +DOI
• Estévez O, Anibarro L, Garet E, Pallares Á, Pena A, Villaverde C, Del Campo V, González-Fernández Á. Identification of candidate host serum and saliva biomarkers for a better diagnosis of active and latent tuberculosis infection. PLoS One. 2020;15(7):e0235859. PMID: 32687494. DOI: 10.1371/journal.pone.0235859. http://www.ncbi.nlm.nih.gov/pubmed/32687494 +Pubmed +DOI
• Fernández-Díaz C, Castañeda S, Melero-González RB, Ortiz-Sanjuán F, Juan-Mas A, Carrasco-Cubero C, Casafont-Solé I, Olivé A, Rodríguez-Muguruza S, Almodóvar-González R, Castellanos-Moreira R, Rodríguez-García SC, Aguilera-Cros C, Villa I, Ordóñez-Palau S, Raya-Alvarez E, Morales-Garrido P, Ojeda-García C, Moreno-Ramos MJ, Bonilla Hernán MG, Hernández Rodríguez I, López-Corbeto M, Andreu JL, Jiménez de Aberásturi JRD, Ruibal-Escribano A, Expósito-Molinero R, Pérez-Sandoval T, López-Robles AM, Carreira-Delgado P, Mena-Vázquez N, Urruticoechea-Arana A, Peralta-Ginés C, Arboleya-Rodríguez L, Narváez García FJ, Palma-Sánchez D, Cervantes Pérez EC, Maiz-Alonso O, Alvarez-Rivas MN, Fernández-Melón J, Vela Casasempere P, Cabezas-Rodríguez I, Castellvi-Barranco I, González-Montagut C, Blanco-Madrigal J, Del Val-Del Amo N, Fito MC, Rodríguez-Gómez M, Salgado-Pérez E, García-Magallón B, Hidalgo-Calleja C, López-Sánchez R, Fernández-Aguado S, Fernández-López JC, Castro-Oreiro S, Serrano-García I, García-Valle A, Romero-Y +Pubmed +DOI
• Gómez-Vaquero C, Fábregas-Canales D, Seoane-Mato D, Sánchez-Piedra C, Díaz-González F, Bustabad-Reyes S, en nombre del Grupo de Trabajo del Proyecto EPISER2016, Grupo de Trabajo del Proyecto EPISER2016 (JM Pego). Fracture risk assessment in the general population in Spain by FRAX® algorithm. EPISER2016 study. Med Clin (Barc). 2020 Mar;154(5):163–70. PMID: 31780217. DOI: 10.1016/j.medcli.2019.05.042. https://pubmed.ncbi.nlm.nih.gov/31780217/ +Pubmed +DOI
• Hernández Cruz B, Alonso F, Calvo Alén J, Pego-Reigosa JM, López-Longo FJ, Galindo-Izquierdo M, Olivé A, Tomero E, Horcada L, Uriarte E, Erausquin C, Sánchez-Atrio A, Montilla C, Santos Soler G, Fernández-Nebro A, Blanco R, Rodríguez-Gómez M, Vela P, Freire M, Díez-Álvarez E, Boteanu AL, Narváez J, Martínez Taboada V, Ruiz-Lucea E, Andreu JL, Fernández-Berrizbeitia O, Hernández-Beriain JÁ, Gantes M, Pérez-Venegas JJ, Ibáñez-Barceló M, Pecondón-Español Á, Marras C, Bonilla G, Castellví I, Moreno M, Raya E, Quevedo Vila VE, Vázquez T, Ruán JI, Muñoz S, Rúa-Figueroa Í, RELESSER (Spanish Society of Rheumatology Systemic Lupus Erythematosus register) group. Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry). Lupus. 2020 Jan;29(1):27–36. PMID: 31801040. DOI: 10.1177/0961203319889667. https://pubmed.ncbi.nlm.nih.gov/31801040/ +Pubmed +DOI
• Johnson SR, Brinks R, Costenbader KH, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger WB, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Aringer M. Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities. Ann Rheum Dis. 2020 Oct;79(10):1333–9. PMID: 32816709. DOI: 10.1136/annrheumdis-2020-217162. http://www.ncbi.nlm.nih.gov/pubmed/32816 +Pubmed +DOI
• Kabala PA, Malvar-Fernández B, Lopes AP, Carvalheiro T, Hartgring SAY, Tang MW, Conde C, Baeten DL, Sleeman M, Tak PP, Connor J, Radstake TR, Reedquist KA, García S. Promotion of macrophage activation by Tie2 in the context of the inflamed synovia of rheumatoid arthritis and psoriatic arthritis patients. Rheumatol (United Kingdom). 2020;59(2):426–38. PMID: 31377797. DOI: 10.1093/rheumatology/kez315. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571483/pdf/kez315.pdf +Pubmed +DOI
• Martínez-López-de-Castro N, Álvarez-Payero M, Samartín-Ucha M, Martín-Vila A, Piñeiro-Corrales G, Rodríguez-Rodríguez M, Maceiras-Pan FJ, Melero-González RB, Pego-Reigosa JM. Biological therapy safety in chronic inflammatory arthropathy patients. Eur J Rheumatol. 2020 May;7(2):53–9. PMID: 32644925. DOI: 10.5152/eurjrheum.2019.19123. https://pubmed.ncbi.nlm.nih.gov/32644925/ +Pubmed +DOI
• Mena-Vázquez N, Fernández-Nebro A, Pego-Reigosa JM, Galindo M, Melissa-Anzola A, Uriarte-Isacelay E, Olivé-Marqués A, Aurrecoechea E, Freire M, Tomero E, García-Villanueva MJ, Stoye C, Salas-Heredia E, Bernal-Vidal JA, Salgado E, Blanco R, Javier Novoa F, Ibáñez-Barcelo M, Torrente-Segarra V, Narvaez J, Calvet J, Moriano Morales C, Ramon Vazquez-Rodriguez T, Garcia de la Peña P, Bohórquez C, Andreu-Sánchez JL, Cobo-Ibañez T, Bonilla G, Lozano-Rivas N, Montilla C, Toyos FJ, De la Fuente JLM, Expósito L, Ruiz-Lucea ME, Vals E, Manero-Ruiz J, Bernal-Vidal JA, Rua-Figueroa I. Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry. Rheumatology (Oxford). 2020 Aug;59(8):2043–51. PMID: 31808534. DOI: 10.1093/rheumatology/kez562. https://pubmed.ncbi.nlm.nih.gov/31808534/ +Pubmed +DOI
• Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, Bae S-C, Brohawn PZ, Pineda L, Berglind A, Tummala R, TULIP-2 Trial Investigators (JM Pego). Trial of Anifrolumab in Active Systemic Lupus Erythematosus. N Engl J Med. 2020 Jan;382(3):211–21. PMID: 31851795. DOI: 10.1056/NEJMoa1912196. http://www.ncbi.nlm.nih.gov/pubmed/31851795 +Pubmed +DOI
• Queiro R, Coto P, Joven B, Rivera R, Navío Marco T, de la Cueva P, Alvarez Vega JL, Narváez Moreno B, Rodriguez Martínez FJ, Pardo Sánchez J, Feced Olmos C, Pujol C, Rodríguez J, Notario J, Pujol Busquets M, García Font M, Galindez E, Pérez Barrio S, Urruticoechea-Arana A, Hergueta M, López Montilla MD, Vélez García-Nieto A, Maceiras F, Rodríguez Pazos L, Rubio Romero E, Rodríguez Fernandez Freire L, Luelmo J, Gratacós J. Current status of multidisciplinary care in psoriatic arthritis in Spain: NEXUS 2.0 project. Reumatol Clin (Engl Ed). 2020 Jan – Feb;16(1):24-31. doi: 10.1016/j.reuma.2018.01.010. Epub 2018 Feb 26. English, Spanish. PubMed PMID: 29496420. +Pubmed +DOI
• Rafael-Vidal C, Pérez N, Altabás I, Garcia S, Pego-Reigosa JM. Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases. Int J Mol Sci. 2020 Sep;21(19):1–14. PMID: 32993066. DOI: 10.3390/ijms21197100. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582977/pdf/ijms-21-07100.pdf +Pubmed +DOI
• Riancho-Zarrabeitia L, Martínez-Taboada V, Rúa-Figueroa I, Alonso F, Galindo-Izquierdo M, Ovalles J, Olivé-Marqués A, Fernández-Nebro A, Calvo-Alén J, Menor-Almagro R, Tomero-Muriel E, Uriarte-Isacelaya E, Botenau A, Andres M, Freire-González M, Santos Soler G, Ruiz-Lucea E, Ibáñez-Barceló M, Castellví I, Galisteo C, Quevedo Vila V, Raya E, Narváez-García J, Expósito L, Hernández-Beriaín JA, Horcada L, Aurrecoechea E, Pego-Reigosa JM. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality. Lupus. 2020 Oct;29(12):1556–65. PMID: 32807021. DOI: 10.1177/0961203320950477. http://www.ncbi.nlm.nih.gov/pubmed/32807021 +Pubmed +DOI
• Rúa-Figueroa I, López-Longo FJ, Del Campo V, Galindo-Izquierdo M, Uriarte E, Torre-Cisneros J, Vela P, Tomero E, Narváez J, Olivé A, Freire M, Salgado E, Andreu JL, Martínez-Taboada V, Calvo-Alén J, Hernández-Cruz B, Raya E, Quevedo V, Expósito Pérez L, Fernández-Nebro A, Ibañez M, Pascual-Valls È, Rúa-Figueroa D, Naranjo A, Pego-Reigosa JM. Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes. J Rheumatol. 2020 Feb;47(2):234–40. PMID: 30988123. DOI: 10.3899/jrheum.180882. https://pubmed.ncbi.nlm.nih.gov/30988123/ +Pubmed +DOI
• Salman-Monte TC, Sanchez-Piedra C, Fernandez Castro M, Andreu JL, Martinez Taboada V, Olivé A, Rosas J, Menor R, Rodríguez B, Garcia Aparicio A, Lopez Longo FJ, Manrique-Arija S, Garcia Vadillo JA, Gil Barato S, López-González R, Galisteo C, Gonzalez Martin J, Ruiz Lucea E, Erausquin C, Melchor S, Moreira B, Raya E, Pego-Reigosa JM, Cid N, Júdez E, Moriano C, Narváez FJ, Corominas H, Garcia Magallon B, Guillen Astete C, Castellvi I, Bohórquez C, Loricera J, Belzunegui J, Illera Ó, Torrente-Segarra V. Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome. Rheumatol Int. 2020 Aug;40(8):1259–65. PMID: 32533289. DOI: 10.1007/s00296-020-04615-3. http://www.ncbi.nlm.nih.gov/pubmed/32533289 +Pubmed +DOI
• Sanchez-Piedra C, Diaz-Torne C, Manero J, Pego-Reigosa JM, Rúa-Figueroa Í, Gonzalez-Gay MA, Gomez-Reino J, Alvaro-Gracia JM, BIOBADASER study group. Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies. Ann Rheum Dis. 2020;79(7):988–90. PMID: 32503857. DOI: 10.1136/annrheumdis-2020-217948. http://www.ncbi.nlm.nih.gov/pubmed/32503857 +Pubmed +DOI
• Torrente-Segarra V, Salman-Monte TC, Rúa-Figueroa Í, Del Campo V, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Mouriño-Rodríguez C, Horcada L, Bohórquez C, Montilla C, Salgado E, Díez-Álvarez E, Blanco R, Andreu JL, Fernández-Berrizbeitia O, Expósito L, Gantes M, Hernández-Cruz B, Pecondón-Español Á, Lozano-Rivas N, Bonilla G, Lois Iglesias A, Rubio-Muñoz P, Ovalles J, Tomero E, Boteanu A, Narvaez J, Freire M, Vela P, Quevedo-Vila V, Juan Mas A, Muñoz-Fernández S, Raya E, Moreno M, Velloso-Feijoo ML, Soler G, Vázquez-Rodríguez TR, Pego-Reigosa JM, RELESSER Study Group of the Spanish Society of Rheumatology (SER) and the Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER). Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER). Semin Arthritis Rheum. 2020 May;50(4):657–62. PMID: 32505871. DOI: 10.1016/j.semarthrit.2020.05.016. http://www.ncbi.nlm.nih.gov/pubmed/32505871 +Pubmed +DOI
• Urruticoechea-Arana A, León-Vázquez F, Giner-Ruiz V, Andréu-Sánchez JL, Olivé-Marqués A, Freire-González M, Pego-Reigosa JM, Muñoz-Fernández S, Román-Ivorra JA, Alegre-Sancho JJ, Vargas-Negrín F, Medina-Abellán M, Cobo-Ibáñez T, Mas-Garriga X, Calvo-Alén J, Costa-Ribas C, Blanco-Vela R, Pérez-Martín Á, Beltrán-Catalán E, Forcada-Gisbert J, Hernández-Miguel MV, Hermosa-Hernán JC, Narváez-García J, Nieto-Pol E, Rúa-Figueroa Í. Development of an application for mobile phones (App) based on the collaboration between the Spanish Society of Rheumatology and Spanish Society of Family Medicine for the referral of systemic autoimmune diseases from primary care to rheumatology. Reumatol Clin. 2020 Sep;16(5 Pt 2):373–7. PMID: 31722849. DOI: 10.1016/j.reuma.2019.09.001. https://pubmed.ncbi.nlm.nih.gov/31722849/ +Pubmed +DOI

Artículos Científicos

• Altabás-González I, Pérez-Gómez N, Pego-Reigosa JM. How to investigate: Suspected systemic rheumatic diseases in patients presenting with muscle complaints. Best Pract Res Clin Rheumatol. 2019 Aug;33(4):101437. PMID: 31810549. DOI: 10.1016/j.berh.2019.101437. http://www.ncbi.nlm.nih.gov/pubmed/31810549 +Pubmed +DOI
• Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019 Jun;78(9):1151–9. PMID: 31383717. DOI: 10.1136/annrheumdis-2018-214819. https://pubmed.ncbi.nlm.nih.gov/31383717/ +Pubmed +DOI
• Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey?Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat?Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz?Irastorza G, Sanchez?Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda?Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego?Reigosa JM, Romero?Diaz J, Rúa?Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019 Sep;71(9):1400–12. PMID: 31385462. DOI: 10.1002/art.40930. https://pubmed.ncbi.nlm.nih.gov/31385462/ +Pubmed +DOI
• De Castro NML, Álvarez-Payero M, Samartín-Ucha M, Martín-Vila A, Piñeiro-Corrales G, Pego Reigosa JM, Rodríguez-Rodríguez M, Melero-González RB, Maceiras-Pan FJ. Adherence to biological therapies in patients with chronic inflammatory arthropathies. Farm Hosp. 2019;43(4):134–9. PMID: 31276446. DOI: 10.7399/fh.11183. https://pubmed.ncbi.nlm.nih.gov/31276446/ +Pubmed +DOI
• López V, Castro ML De, Ucha S, Meléndez F. Evaluación de la satisfacción global de los pacientes con nutrición enteral domiciliaria en la consulta de farmacia hospitalaria?: estudio. Rev Nutr Clin y Diet Hosp. 2019;39(3):146–53. DOI: 10.12873/393vazquez. https://runa.sergas.es/xmlui/handle/20.500.11940/12681 +DOI
• Martínez-López De Castro N, Samartín-Ucha M, Martín-Vila A, Álvarez-Payero M, Piñeiro-Corrales G, Pego-Reigosa JM. Content analysis of Twitter in relation to biological treatments for chronic inflammatory arthropathies: an exploratory study. Eur J Hosp Pharm Sci Pract. 2019 May;26(3):124–8. PMID: 31428318. DOI: 10.1136/ejhpharm-2017-001402. http://www.ncbi.nlm.nih.gov/pubmed/31428318 +Pubmed +DOI
• Rosas J, Sánchez-Piedra C, Fernández-Castro M, Andreu JL, Martínez-Taboada V, Olivé A, SJÖGRENSER Group, part of the Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group-EASSER (Marina Rodríguez López; Coral Mouriño; JMP. ESSDAI activity index of the SJÖGRENSER cohort: analysis and comparison with other European cohorts. Rheumatol Int. 2019 Jun;39(6):991–9. PMID: 30891620. DOI: 10.1007/s00296-019-04285-w. http://www.ncbi.nlm.nih.gov/pubmed/30891620 +Pubmed +DOI
• Samartín-Ucha M, Castro-Domínguez J, Fernández-Vega H, Piñeiro-Corrales G, Coordinating Group on Safety in High-Alert-Medication in Xerencia de Xestión Integrada de Vigo VS (Noemí M-L-CAP-C. Devising of a risk map on the management of high risk alert medication in a high level university hospital. Farm Hosp. 2019;43(3):110–5. PMID: 31072289. DOI: 10.7399/fh.11175. http://www.ncbi.nlm.nih.gov/pubmed/31072289 +Pubmed +DOI
• Samartín-Ucha M, Piñeiro-Corrales G, Continuity of Care Group from the EOXI Vigo. Model of teleconsultation pharmaceutical integrated in the electronic clinical history of the patient. Farm Hosp. 2019;43(1):1–5. PMID: 30624166. DOI: 10.7399/fh.10937. http://www.ncbi.nlm.nih.gov/pubmed/30624166 +Pubmed +DOI
• Seoane-Mato D, Sánchez-Piedra C, Silva-Fernández L, Sivera F, Blanco FJ, Pérez Ruiz F, Juan-Mas A, Pego-Reigosa JM, Narváez J, Quilis Martí N, Cortés Verdú R, Antón-Pagés F, Quevedo Vila V, Garrido Courel L, Del Amo NDV, Paniagua Zudaire I, Añez Sturchio G, Medina Varo F, Ruiz Tudela MDM, Romero Pérez A, Ballina J, Brandy García A, Fábregas Canales D, Font Gayá T, Bordoy Ferrer C, González Álvarez B, Casas Hernández L, Álvarez Reyes F, Delgado Sánchez M, Martínez Dubois C, Sánchez-Fernández SÁ, Rojas Vargas LM, García Morales PV, Olivé A, Rubio Muñoz P, Larrosa M, Navarro Ricos N, Graell Martín E, Chamizo E, Chaves Chaparro L, Rojas Herrera S, Pons Dolset J, Polo Ostariz MÁ, Ruiz-Alejos Garrido S, Macía Villa C, Cruz Valenciano A, González Gómez ML, Morcillo Valle M, Palma Sánchez D, Moreno Martínez MJ, Mayor González M, Atxotegi Sáenz de Buruaga J, Urionagüena Onaindia I, Blanco Cáceres BA, Díaz-González F, Bustabad S. Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims an +Pubmed +DOI
• Silva-Fernández L, Otón T, Askanase A, Carreira P, López-Longo FJ, Olivé A, Rúa-Figueroa Í, Narváez J, Ruiz-Lucea E, Andrés M, Calvo E, Toyos F, Alegre-Sancho JJ, Tomero E, Montilla C, Zea A, Uriarte E, Calvo-Alén J, Marras C, Martínez-Taboada VM, Belmonte-López MÁ, Rosas J, Raya E, Bonilla G, Freire M, Pego-Reigosa JM, Millán I, Hughes-Morley A, Andreu JL, from the Spanish Society for Rheumatology Systemic Autoimmune Diseases Study Group (EAS-SER). Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature. Reumatol Clin. 2019 May;15(1):34–42. PMID: 28528869. DOI: 10.1016/j.reuma.2017.04.005. http://www.ncbi.nlm.nih.gov/pubmed/28528869 +Pubmed +DOI
• Tejera Segura B, Rua-Figueroa I, Pego-Reigosa JM, Del Campo V, Wincup C, Isenberg D, Rahman A. Can we validate a clinical score to predict the risk of severe infection in patients with systemic lupus erythematosus? A longitudinal retrospective study in a British Cohort. BMJ Open. 2019;9(6):1–9. PMID: 31203250. DOI: 10.1136/bmjopen-2018-028697. https://pubmed.ncbi.nlm.nih.gov/31203250/ +Pubmed +DOI
• Torrente-Segarra V, Salman Monte TC, Rúa-Figueroa I, De Uña-Álvarez J, Balboa-Barreiro V, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Mouriño-Rodríguez C, Horcada L, Sánchez-Atrio A, Montilla C, Salgado E, Díez-Álvarez E, Blanco R, Andreu JL, Fernández-Berrizbeitia O, Hernández-Beriain JA, Gantes M, Hernández-Cruz B, Pecondón-Español A, Marras C, Bonilla G, Pego-Reigosa JM, RELESSER Study Group of the Spanish Society of Rheumatology (SER) and the Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER). Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER). Semin Arthritis Rheum. 2019 Sep;48(6):1025–9. PMID: 30344081. DOI: 10.1016/j.semarthrit.2018.09.005. http://www.ncbi.nlm.nih.gov/pubmed/30344081 +Pubmed +DOI

Artículos Científicos

• Julià A, López-Longo FJ, Pérez Venegas JJ, Bonàs-Guarch S, Olivé À, Andreu JL, Aguirre-Zamorano MÁ, Vela P, Nolla JM, de la Fuente JLM, Zea A, Pego-Reigosa JM, Freire M, Díez E, Rodríguez-Almaraz E, Carreira P, Blanco R, Taboada VM, López-Lasanta M, Corbeto ML, Mercader JM, Torrents D, Absher D, Marsal S, Fernández-Nebro A. Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus. Arthritis Res Ther. Arthritis Research & Therapy; 2018 May;20(1):100. PMID: 29848360. DOI: 10.1186/s13075-018-1604-1. http://www.ncbi.nlm.nih.gov/pubmed/29848360 +Pubmed +DOI
• Martínez-López de Castro N, Matilla-Fernández MB, Fraga-Fuentes MD, Mangues-Bafalluy I, Asensi-Díez R, Cajaraville-Ordoñana G. Spanish Society of Hospital Pharmacy position paper on biosimilar medicines. Farm Hosp. 2018 Jul;42(4):180–3. PMID: 29959844. DOI: 10.7399/fh.10973. http://www.ncbi.nlm.nih.gov/pubmed/29959844 +Pubmed +DOI
• Martínez-López-de-Castro N, Álvarez-Payero M, Martín-Vila A, Samartín-Ucha M, Iglesias-Neiro P, Gayoso-Rey M, Feijoo-Meléndez D, Casanova-Martínez C, Fariña-Conde M, Piñeiro-Corrales G. Factors associated with patient satisfaction in an outpatient hospital pharmacy. Eur J Hosp Pharm. 2018 Jul;25(4):183–8. DOI: 10.1136/ejhpharm-2016-001192. http://ejhp.bmj.com/lookup/doi/10.1136/ejhpharm-2016-001192 +DOI
• Narváez J, Borrell H, Sánchez-Alonso F, Rúa-Figueroa I, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Fernández-Nebro A, Olivé A, Andreu JL, Martínez-Taboada V, Nolla JM, Pego-Reigosa JM, RELESSER Study Group. Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort. Arthritis Res Ther. Arthritis Research & Therapy; 2018;20(1):280. PMID: 30567600. DOI: 10.1186/s13075-018-1776-8. http://www.ncbi.nlm.nih.gov/pubmed/30567600 +Pubmed +DOI
• Romero-Ventosa EY, Gayoso-Rey M, Samartín-Ucha M, Lamas-Domínguez P, Rubianes-González M, Rodríguez-Lorenzo D, Rodríguez-Vázquez MH, García-Comesaña J, Piñeiro-Corrales G. Pharmacotherapeutic Reports as Tools for Detecting Discrepancies in Continuity of Care. Ther Innov Regul Sci. 2018 Jan;52(1):94–9. PMID: 29714617. DOI: 10.1177/2168479017716716. http://www.ncbi.nlm.nih.gov/pubmed/29714617 +Pubmed +DOI

Artículos Científicos

• Álvarez-Payero M, Valeiras-Muñoz C, Lion-Vázquez S, Piñeiro-Corrales G, Muñoz-García D, Midaglia L. Experience with fampridine in clinical practice: analysis of a possible marker of clinical response. Int J Neurosci. 2017 Oct;127(10):915–22. PMID: 28054826. DOI: 10.1080/00207454.2017.1279614. IF2017: 1.848; Q4. http://www.ncbi.nlm.nih.gov/pubmed/28054826 +Pubmed +DOI
• Blanco-Pérez JJ, Arnalich Montiel V, Guerra Vales JL. Plastic bronchitis in a patient with silicosis. Arch Bronconeumol. 2017 Sep;53(9):516. PMID: 28365186. DOI: 10.1016/j.arbres.2017.02.012. IF2017: 2.633; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28365186 +Pubmed +DOI
• Cabrerizo M, García-Iñiguez JP, Munell F, Amado A, Madurga-Revilla P, Rodrigo C, Pérez S, Martínez-Sapiña A, Antón A, Suárez G, Rabella N, Del Campo V, Otero A, Masa-Calles J. First Cases of Severe Flaccid Paralysis Associated With Enterovirus D68 Infection in Spain, 2015-2016. Pediatr Infect Dis J. 2017 Dec;36(12):1214–6. PMID: 28661963. DOI: 10.1097/INF.0000000000001668. IF2017: 2.305; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28661963 +Pubmed +DOI
• Calvo-Alén J, Monteagudo I, Salvador G, Vázquez-Rodríguez TR, Tovar-Beltrán J V, Vela P, Maceiras F, Bustabad S, Román-Ivorra JA, Díaz-Miguel C, Rosas J, Raya E, Carmona L, Cea-Calvo L, Arteaga MJ, Fernández S, Marras C. Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study. Clin Exp Rheumatol. 2017 May;35(3):423–30. PMID: 28032846. IF2017: 3.201; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28032846 +Pubmed
• Clowse MEB, Wallace DJ, Furie RA, Petri MA, Pike MC, Leszczy?ski P, Neuwelt CM, Hobbs K, Keiserman M, Duca L, Kalunian KC, Galateanu C, Bongardt S, Stach C, Beaudot C, Kilgallen B, Gordon C, EMBODY Investigator Group ( JM Pego-Reigosa). Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials. Arthritis Rheumatol (Hoboken, NJ). 2017 Feb;69(2):362–75. PMID: 27598855. DOI: 10.1002/art.39856. IF2017: 7.871; D1. http://www.ncbi.nlm.nih.gov/pubmed/27598855 +Pubmed +DOI
• Cordero OJ, Varela-Calviño R, López-González T, Grujic M, Juranic Z, Mouriño C, Hernández-Rodríguez Í, Rodríguez-López M, de la Iglesia BA, Pego-Reigosa JM. Anti-CD26 autoantibodies are involved in rheumatoid arthritis and show potential clinical interest. Clin Biochem. 2017 Nov;50(16–17):903–10. PMID: 28599787. DOI: 10.1016/j.clinbiochem.2017.06.001. IF2017: 2.584; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28599787 +Pubmed +DOI
• de Castro ML, Sanromán L, Martín A, Figueira M, Martínez N, Hernández V, Del Campo V, Pineda JR, Martínez-Cadilla J, Pereira S, Rodríguez Prada JI. Assessing medication adherence in inflammatory bowel diseases. A comparison between a self-administered scale and a pharmacy refill index. Rev Esp Enferm Dig. 2017 Aug;109(8):542–51. PMID: 28679280. DOI: 10.17235/reed.2017.5137/2017. IF2017: 1.632; Q4. http://www.ncbi.nlm.nih.gov/pubmed/28679280 +Pubmed +DOI
• López LC, De Benito Basanta L, Bustelo MS, Corral AB, Lorenzo JRF. Enfermedad de Vogt-Koyanagi-Harada: Una causa rara de uveítis. Acta Pediatr Esp. 2017 Jul;75(7–8):e141–3. IF2017: N/A. https://www.scopus.com/inward/record.uri?eid=2-s2.0-85034649037&partnerID=40&md5=662f74a7d64b62dd8a347eacde728846 Enlace
• Martínez López JA, García Vivar ML, Cáliz R, Freire M, Galindo M, Hernández MV, López Longo FJ, Martínez Taboada V, Pego Reigosa JM, Rubio E, Trujillo E, Vela-Casasempere P. Recommendations for the evaluation and management of patients with rheumatic autoimmune and inflammatory diseases during the reproductive age, pregnancy, postpartum and breastfeeding. Reumatol Clin. 2017 Sep;13(5):264–81. PMID: 27321859. DOI: 10.1016/j.reuma.2016.05.003. IF2017: N/A. http://www.ncbi.nlm.nih.gov/pubmed/27321859 +Pubmed +DOI
• Riveros Frutos A, Casas I, Rúa-Figueroa I, López-Longo FJ, Calvo-Alén J, Galindo M, Fernández-Nebro A, Pego-Reigosa JM, Olivé Marqués A, RELESSER Group part of the SS of RSADSG (EASSER). Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort. Lupus. 2017 Jun;26(7):698–706. PMID: 27799439. DOI: 10.1177/0961203316673728. IF2017: 2.969; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27799439 +Pubmed +DOI
• Rúa-Figueroa I, Fernández Castro M, Andreu JL, Sanchez-Piedra C, Martínez-Taboada V, Olivé A, López-Longo J, Rosas J, Galindo M, Calvo-Alén J, Fernández-Nebro A, Alonso F, Rodríguez-Lozano B, Alberto García Vadillo J, Menor R, Narváez FJ, Erausquin C, García-Aparicio Á, Tomero E, Manrique-Arija S, Horcada L, Uriarte E, Gil S, Blanco R, López-González R, Boteanu A, Freire M, Galisteo C, Rodríguez-Gómez M, Díez-Álvarez E, Pego-Reigosa JM, Sjogrenser and Relesser Researchers and EAS-SER Group. Comorbidities in Patients With Primary Sjögren´s Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study. Arthritis Care Res (Hoboken). 2017 Jan;69(1):38–45. PMID: 27564390. DOI: 10.1002/acr.23015. IF2017: 4.149; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27564390 +Pubmed +DOI
• Rúa-Figueroa Í, López-Longo J, Galindo-Izquierdo M, Calvo-Alén J, Del Campo V, Olivé-Marqués A, Pérez-Vicente S, Fernández-Nebro A, Andrés M, Erausquin C, Tomero E, Horcada L, Uriarte E, Freire M, Montilla C, Sánchez-Atrio A, Santos G, Boteanu A, Díez-Álvarez E, Narváez J, Martínez-Taboada V, Silva-Fernández L, Ruiz-Lucea E, Andreu JL, Hernández-Beriain JÁ, Gantes M, Hernández-Cruz B, Pérez-Venegas J, Pecondón-Español Á, Marras C, Ibáñez-Barceló M, Bonilla G, Torrente V, Castellví I, Alegre JJ, Calvet J, Marenco JL, Raya E, Vázquez T, Quevedo V, Muñoz-Fernández S, Rodríguez-Gómez M, Ibáñez J, Pego-Reigosa JM. Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2017 Aug;47(1):38–45. PMID: 28259425. DOI: 10.1016/j.semarthrit.2017.01.010. IF2017: 4.365; Q1. http://www.ncbi.nlm.nih.gov/pubmed/28259425 +Pubmed +DOI
• Schneider M, Mosca M, Pego-Reigosa J-MM, Gunnarsson I, Maurel F, Garofano A, Perna A, Porcasi R, Devilliers H. Cross-cultural validation of lupus impact tracker in five European clinical practice settings. Rheumatol (United Kingdom). 2017 May;56(5):818–28. PMID: 28204765. DOI: 10.1093/rheumatology/kew492. IF2017: 5.245; Q1. http://www.ncbi.nlm.nih.gov/pubmed/28204765 +Pubmed +DOI
• Torrente-Segarra V, Salman Monte TC, Rúa-Figueroa I, Sánchez-Alonso F, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Ibañez-Ruán J, Horcada L, Sánchez-Atrio A, Montilla C, Melero González RB, Díez-Álvarez E, Martinez-Taboada V, Andreu JL, Fernández-Berrizbeitia O, Hernández-Beriain JÁ, Gantes M, Hernández-Cruz B, Pecondón-Español Á, Marras C, Bonilla G, Pego-Reigosa JM, RELESSER Study Group of the Spanish Society of Rheumatology (SER) and the Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER). Juvenile- and adult-onset systemic lupus erythematosus: a comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER). Clin Exp Rheumatol. 2017 Jun;35(6):1047–55. PMID: 28628467. IF2017: 3.201; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28628467 +Pubmed

Artículos Científicos

• Alonso A, Julià A, Vinaixa M, Domènech E, Fernández-Nebro A, Cañete JD, Ferrándiz C, Tornero J, Gisbert JP, Nos P, Casbas AG, Puig L, González-Álvaro I, Pinto-Tasende JA, Blanco R, Rodríguez MA, Beltran A, Correig X, Marsal S, IMID Consortium. Urine metabolome profiling of immune-mediated inflammatory diseases. BMC Med. BMC Medicine; 2016 Sep;14(1):133. PMID: 27609333. DOI: 10.1186/s12916-016-0681-8. IF2016: 7.901; D1. http://www.ncbi.nlm.nih.gov/pubmed/27609333 +Pubmed +DOI
• Blanco-Pérez JJ, Pérez González A, Morano Amado LE, Guerra Vales JL, Vázquez Gallardo R, Salgado Barreira Á, Cruz Carmona MJ, González Barcala FJ. Clinical Significance of Environmental Mycobacteria Isolated From Respiratory Specimens of Patients With and Without Silicosis. Arch Bronconeumol. 2016 Mar;52(3):145–50. PMID: 26304492. DOI: 10.1016/j.arbres.2015.07.007. IF2016: 2.979; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26304492 +Pubmed +DOI
• Galindo-Izquierdo M, Rodriguez-Almaraz E, Pego-Reigosa JM, López-Longo FJ, Calvo-Alén J, Olivé A, Fernández-Nebro A, Martinez-Taboada V, Vela-Casasempere P, Freire M, Narváez FJ, Rosas J, Ibáñez-Barceló M, Uriarte E, Tomero E, Zea A, Horcada L, Torrente V, Castellvi I, Calvet J, Menor-Almagro R, Zamorano MAA, Raya E, Díez-Álvarez E, Vázquez-Rodríguez T, García de la Peña P, Movasat A, Andreu JL, Richi P, Marras C, Montilla-Morales C, Hernández-Cruz B, Marenco de la Fuente JL, Gantes M, Úcar E, Alegre-Sancho JJ, Manero J, Ibáñez-Ruán J, Rodríguez-Gómez M, Quevedo V, Hernández-Beriaín J, Silva-Fernández L, Alonso F, Pérez S, Rúa-Figueroa I, RELESSER Group from SS of RSADSG (EASSER). Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER). Medicine (Baltimore). 2016 Mar;95(9):e2891. PMID: 26945378. DOI: 10.1097/MD.0000000000002891. IF2016: 1.804; Q2. http://www.ncbi.nlm.nih.gov/pubme +Pubmed +DOI
• Pego-Reigosa JM, Lois-Iglesias A, Rúa-Figueroa Í, Galindo M, Calvo-Alén J, de Uña-Álvarez J, Balboa-Barreiro V, Ibáñez Ruan J, Olivé A, Rodríguez-Gómez M, Fernández Nebro A, Andrés M, Erausquin C, Tomero E, Horcada Rubio L, Uriarte Isacelaya E, Freire M, Montilla C, Sánchez-Atrio AI, Santos-Soler G, Zea A, Díez E, Narváez J, Blanco-Alonso R, Silva-Fernández L, Ruiz-Lucea ME, Fernández-Castro M, Hernández-Beriain JÁ, Gantes-Mora M, Hernández-Cruz B, Pérez-Venegas J, Pecondón-Español Á, Marras Fernández-Cid C, Ibáñez-Barcelo M, Bonilla G, Torrente-Segarra V, Castellví I, Alegre JJ, Calvet J, Marenco de la Fuente JL, Raya E, Vázquez-Rodríguez TR, Quevedo-Vila V, Muñoz-Fernández S, Otón T, Rahman A, López-Longo FJ. Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry. Rheumatology (Oxford). 2016 Jul;55(7):1243–50. PMID: 27018057. DOI: 10.1093/rheumato +Pubmed +DOI
• Rodríguez Huerta MD, Trujillo-Martín MM, Rúa-Figueroa Í, Cuellar-Pompa L, Quirós-López R, Serrano-Aguilar P, Spanish SLE CPG Development Group (JM Pego-Reigosa; N Martínez López de Castro). Healthy lifestyle habits for patients with systemic lupus erythematosus: A systemic review. Semin Arthritis Rheum. Elsevier; 2016 Feb;45(4):463–70. PMID: 26522137. DOI: 10.1016/j.semarthrit.2015.09.003. IF2016: 4.498; Q1. http://www.ncbi.nlm.nih.gov/pubmed/26522137 +Pubmed +DOI
• Romero-Ventosa EY, Samartín-Ucha M, Martín-Vila A, Martínez-Sánchez ML, Rey Gómez-Serranillos I, Pineiro-Corrales G. Multidisciplinary teams involved: detection of drug-related problems through continuity of care. Farm Hosp. 2016 Nov;40(n06):529–43. PMID: 27894227. DOI: 10.7399/fh.2016.40.6.10506. IF2016: N/A. http://www.ncbi.nlm.nih.gov/pubmed/27894227 +Pubmed +DOI
• Schneider M, Mosca M, Pego-Reigosa JM, Hachulla E, Teh L-S, Perna A, Koscielny V, Pike J, Lobosco S, Apolone G. Understanding remission in real-world lupus patients across five European countries. Lupus. 2016 Apr;25(5):505–12. PMID: 26635245. DOI: 10.1177/0961203315619030. IF2016: 2.454; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26635245 +Pubmed +DOI
• Torrente-Segarra V, Salman-Monte TC, Rúa-Figueroa Í, Pérez-Vicente S, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Ibañez-Ruán J, Horcada L, Sánchez-Atrio A, Montilla C, Rodríguez-Gómez M, Díez-Álvarez E, Martinez-Taboada V, Andreu JL, Fernández-Berrizbeitia O, Hernández-Beriain JA, Gantes M, Hernández-Cruz B, Pecondón-Español Á, Marras C, Bonilla G, Pego-Reigosa JM, RELESSER Study Group of the Spanish Society of Rheumatology (SER), Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER). Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2016 Nov;34(2 Suppl 96):S40-7. PMID: 26575317. IF2015: 2.495; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26575317 +Pubmed
• Trujillo-Martín MM, Rúa-Figueroa Fernández de Larrinoa I, Ruíz-Irastorza G, Pego-Reigosa JM, Sabio Sánchez JM, Serrano-Aguilar P, en nombre del Grupo Elaborador de la GPC-LES. [Clinical practice guidelines for systemic lupus erythematosus: Recommendations for general clinical management]. Med Clin (Barc). 2016 May;146(9):413.e1-14. PMID: 26975887. DOI: 10.1016/j.medcli.2016.01.013. IF2016: 1.125; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26975887 +Pubmed +DOI

Artículos Científicos

• Blanco-Pérez JJ, Pérez González A, Guerra Vales JL, Melero Gonzalez R, Pego Reigosa JM. Shrinking Lung in Primary Sjogrën Syndrome Successfully Treated with Rituximab. Arch Bronconeumol. 2015 Sep;51(9):475–6. PMID: 25582545. DOI: 10.1016/j.arbres.2014.11.016. IF2015: 1.771; Q3. http://www.ncbi.nlm.nih.gov/pubmed/25582545 +Pubmed +DOI
• Cordero OJ, Varela-Calviño R, López-González T, Calviño-Sampedro C, Viñuela JE, Mouriño C, Hernández-Rodríguez Í, Rodríguez-López M, Aspe de la Iglesia B, Pego-Reigosa JM, Pego JM. CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis. PLoS One. 2015 Jul;10(7):e0131992. PMID: 26177310. DOI: 10.1371/journal.pone.0131992. IF2015: 3.057; Q1. http://www.ncbi.nlm.nih.gov/pubmed/26177310 +Pubmed +DOI
• Fernández Álvarez R, Martínez González C, Quero Martínez A, Blanco-Pérez JJ, Carazo Fernández L, Prieto Fernández A. Guidelines for the diagnosis and monitoring of silicosis. Arch Bronconeumol. 2015 Feb;51(2):86–93. PMID: 25479706. DOI: 10.1016/j.arbres.2014.07.010. IF2015: 1.771; Q3. http://www.ncbi.nlm.nih.gov/pubmed/25479706 +Pubmed +DOI
• Fernández-Nebro A, Rúa-Figueroa Í, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Ordóñez-Cañizares C, Martín-Martínez MA, Blanco R, Melero-González R, Ibáñez-Rúan J, Bernal-Vidal JA, Tomero-Muriel E, Uriarte-Isacelaya E, Horcada-Rubio L, Freire-González M, Narváez J, Boteanu AL, Santos-Soler G, Andreu JL, Pego-Reigosa JM, EAS-SER (Systemic Diseases Study Group of Spanish Society of Rheumatology). Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry. Medicine (Baltimore). 2015 Jul;94(29):e1183. PMID: 26200625. DOI: 10.1097/MD.0000000000001183. IF2015: 2.133; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26200625 +Pubmed +DOI
• Ferraz-Falcao JR, Cadaval-Rodríguez T, Rodríguez-Iglesia RM, del Campo-Pérez VM. [Palliative care needs in the inmobilized population of a Primary Care area in Vigo Spain]. Semergen. 2015 Sep;41(6):305–14. PMID: 25442465. DOI: 10.1016/j.semerg.2014.06.017. IF2015: N/A. http://www.ncbi.nlm.nih.gov/pubmed/25442465 +Pubmed +DOI
• García de la Peña Lefebvre P, Nishishinya MB, Pereda CA, Loza E, Sifuentes Giraldo WA, Román Ivorra JA, Carreira P, Rúa-Figueroa I, Pego-Reigosa JM, Muñoz-Fernández S. Efficacy of Raynaud´s phenomenon and digital ulcer pharmacological treatment in systemic sclerosis patients: a systematic literature review. Rheumatol Int. 2015 Sep;35(9):1447–59. PMID: 25824427. DOI: 10.1007/s00296-015-3241-1. IF2015: 1.702; Q3. http://www.ncbi.nlm.nih.gov/pubmed/25824427 +Pubmed +DOI
• González Chávez J, Asensi Diez R, Tamayo Bermejo R, Alegre Del Rey EJ, Martínez López de Castro N. [Vedolizumab in Crohn Disease genesis-sefh drug evaluation report]. Farm Hosp. 2015 Sep;39(5):297–308. PMID: 26546942. DOI: 10.7399/fh.2015.39.5.8981. IF2015: N/A. http://www.ncbi.nlm.nih.gov/pubmed/26546942 +Pubmed +DOI
• Inês L, Silva C, Galindo M, López-Longo FJ, Terroso G, Romão VC, Rúa-Figueroa I, Santos MJ, Pego-Reigosa JM, Nero P, Cerqueira M, Duarte C, Miranda LC, Bernardes M, Gonçalves MJ, Mouriño-Rodríguez C, Araújo F, Raposo A, Barcelos A, Couto M, Abreu P, Otón-Sanchez T, Macieira C, Ramos F, Branco JC, Silva JAP, Canhão H, Calvo-Alén J, Rheumatic Diseases Registry of the Portuguese Society of Rheumatology, Registry of Systemic Lupus Erythematosus Patients of the Spanish Society of Rheumatology. Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort. Arthritis Care Res (Hoboken). 2015 Aug;67(8):1180–5. PMID: 25581417. DOI: 10.1002/acr.22539. IF2015: 3.229; Q2. http://www.ncbi.nlm.nih.gov/pubmed/25581417 +Pubmed +DOI
• Nishishinya MB, Pereda CA, Muñoz-Fernández S, Pego-Reigosa JM, Rúa-Figueroa I, Andreu J-L, Fernández-Castro M, Rosas J, Loza Santamaría E. Identification of lymphoma predictors in patients with primary Sjögren´s syndrome: a systematic literature review and meta-analysis. Rheumatol Int. 2015 Jan;35(1):17–26. PMID: 24899571. DOI: 10.1007/s00296-014-3051-x. IF2015: 1.702; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24899571 +Pubmed +DOI
• Pego-Reigosa JM, Rúa-Figueroa Í, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, del Campo V, García-Yébenes MJ, Loza-Santamaría E, Blanco R, Melero-González R, Vela-Casasempere P, Otón-Sánchez T, Tomero-Muriel E, Uriarte-Isacelaya E, Fito-Manteca MC, Freire-González M, Narváez J, Fernández-Nebro A, Zea-Mendoza A, Rosas J, Carlos Rosas J, RELESSER Group from the SS of RSADSG (EASSER). Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosus. Lupus. 2015 Jun;24(7):720–9. PMID: 25516473. DOI: 10.1177/0961203314563818. IF2015: 2.118; Q3. http://www.ncbi.nlm.nih.gov/pubmed/25516473 +Pubmed +DOI
• Rúa-Figueroa Í, Richi P, López-Longo FJ, Galindo M, Calvo-Alén J, Olivé-Marqués A, Loza-Santamaría E, Vicente SP, Erausquin C, Tomero E, Horcada L, Uriarte E, Sánchez-Atrio A, Rosas J, Montilla C, Fernández-Nebro A, Rodríguez-Gómez M, Vela P, Blanco R, Freire M, Silva L, Díez-Álvarez E, Ibáñez-Barceló M, Zea A, Narváez J, Martínez-Taboada V, Marenco JL, de Castro MF, Fernández-Berrizbeitia O, Hernández-Beriain JÁ, Gantes M, Hernández-Cruz B, Pérez-Venegas JJ, Pecondón Á, Marras C, Carreira P, Bonilla G, Torrente V, Castellví I, Alegre J, Moreno M, Raya E, de la Peña PG, Vázquez T, Aguirre Á, Quevedo V, Pego-Reigosa JM, EAS-SER (Systemic Diseases Study Group of the Spanish Society of Rheumatology). Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences. Medicine (Baltimore). 2015 Jan;94(1):e267. PMID: 25569641. DOI: 10.1097/MD.0000000000000 +Pubmed +DOI
• Serrano-Aguilar P, Trujillo-Martin M del M, Pérez de la Rosa A, Cuellar-Pompa L, Saavedra-Medina H, Linertova R, Perestelo-Perez L, Perez-Ramos J, Rivero-Santana A, Spanish SLE CPG Development Group (JM Pego-Reigosa; N Martínez-López de Castro). Patient participation in a Clinical Guideline Development for Systemic Lupus Erythematosus. Patient Educ Couns. 2015 Sep;98(9):1156–63. PMID: 26095343. DOI: 10.1016/j.pec.2015.05.022. IF2015: 2.232; D1. http://www.ncbi.nlm.nih.gov/pubmed/26095343 +Pubmed +DOI

Guías de Práctica Clínica

• Grupo de trabajo de la Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico, Alarcón-Torres I, Calvo-Alén J, Cuadrado-Lozano MJ, del Pino Sedeño TM, Frutos-Sanz MÁ, García-Díaz S, Jarque-Ramos I, Martín-Gómez MA, Martínez-Ibáñez MT, Martínez-López de Castro N, Melwani PM, Pazos-Casal P, Pego-Reigosa JM, Rúa-Figueroa Fernández de Larrinoa I, Ruíz-Irastorza G, Serrano-Aguilar P, Sabio Sánchez JM. Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico. Ministerio de Sanidad, Servicios Sociales e Igualdad. Servicio de Evaluación del Servicio Canario de la Salud; 2015. Guías de Práctica Clínica en el SNS.; 2015. NIPO: 680-15-083-4. ISBN: 9788439380894. http://portal.guiasalud.es/GPC/GPC_549_Lupus_SESCS_compl.pdf Enlace

Artículos Científicos

• Álvarez-Payero M, Martínez López de Castro N, Ucha Samartín M, Martín Vila A, Vázquez López C, Piñeiro Corrales G. Medication non-adherence as a cause of hospital admissions. Farm Hosp. 2014 Jul;38(4):328–33. PMID: 25137166. DOI: 10.7399/fh.2014.38.4.7660. IF: N/A. http://www.ncbi.nlm.nih.gov/pubmed/?term=25137166 +Pubmed +DOI
• Cobo-Ibáñez T, Loza-Santamaría E, Pego-Reigosa JM, Marqués AO, Rúa-Figueroa I, Fernández-Nebro A, Cáliz Cáliz R, López Longo FJ, Muñoz-Fernández S. Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: a systematic review. Semin Arthritis Rheum. 2014 Oct;44(2):175–85. PMID: 24830791. DOI: 10.1016/j.semarthrit.2014.04.002. IF: 3.925; Q1. http://www.ncbi.nlm.nih.gov/pubmed/24830791 +Pubmed +DOI
• Fernández-Nebro A, Marenco JL, López-Longo F, Galindo M, Hernández-Cruz BE, Narváez J, Rúa-Figueroa I, Raya-Alvarez E, Zea A, Freire M, Sánchez-Atrio AI, García-Vicuña R, Pego-Reigosa JM, Manrique-Arija S, Nieves-Martín L, Carreño L. The effects of rituximab on the lipid profile of patients with active systemic lupus erythematosus: results from a nationwide cohort in Spain (LESIMAB). Lupus. 2014 Sep;23(10):1014–22. PMID: 24833667. DOI: 10.1177/0961203314534909. IF: 2.197; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24833667 +Pubmed +DOI
• Piñeiro Corrales G, Vazquez Lopez C, Álvarez-Payero M, Vázquez López C, Álvarez Payero M. Efecto del tratamiento farmacológico en el estado nutricional del paciente neurológico [Effect of pharmacologic treatment of the nutritional status of neurologic patients]. Nutr Hosp. 2014 Jan;29 Suppl 2:47–56. PMID: 25077345. IF: 1.040; Q4. http://www.ncbi.nlm.nih.gov/pubmed/25077345 +Pubmed
• Rúa-Figueroa I, López-Longo FJ, Calvo-Alén J, Galindo-Izquierdo M, Loza E, García de Yebenes MJ, Pego-Reigosa JM. National registry of patients with systemic lupus erythematosus of the Spanish Society of Rheumatology: objectives and methodology. Reumatol Clin. 2014 Jan;10(1):17–24. PMID: 23871155. DOI: 10.1016/j.reuma.2013.04.013. IF: N/A. http://www.ncbi.nlm.nih.gov/pubmed/23871155 +Pubmed +DOI
• Silva-Fernández L, Loza E, Martínez-Taboada VM, Blanco R, Rúa-Figueroa I, Pego-Reigosa JM, Muñoz-Fernández S, Systemic Autoimmune Diseases Study Group of the Spanish Society for Rheumatology (EAS-SER). Biological therapy for systemic vasculitis: a systematic review. Semin Arthritis Rheum. 2014 Feb;43(4):542–57. PMID: 23978781. DOI: 10.1016/j.semarthrit.2013.07.010. IF: 3.925; Q1. http://www.ncbi.nlm.nih.gov/pubmed/23978781 +Pubmed +DOI
• Tejera Segura B, Holgado S, Mateo L, Pego-Reigosa JM, Carnicero Iglesias M, Olivé A. Síndrome de Löfgren: estudio de 80 casos. Med Clin (Barc). 2014 Aug;143(4):166–9. PMID: 24855899. DOI: 10.1016/j.medcli.2014.02.029. IF: 1.417; Q2. http://www.ncbi.nlm.nih.gov/pubmed/24855899 +Pubmed +DOI
• Ucha Sanmartin M, Martín Vila A, López Vidal C, Caaamaño Barreiro M, Piñeiro Corrales G. [Prevention of medication errors in healthcare transition of patients treated with apomorphine]. Farm Hosp. 2014 May;38(3):227–30. PMID: 24951908. DOI: 10.7399/fh.2014.38.3.7430. IF: N/A. http://www.ncbi.nlm.nih.gov/pubmed/24951908 +Pubmed +DOI